Keywords: novartis/gpc, sparc, trial, continues, after, interim, meeting

Novartis/GPC's SPARC trial continues after interim meeting

Article | 19 June 2006

Print This

Swiss drug major Novartis, German drugmaker GPC Biotech AG and the USA's Pharmion Corp say that the independent Data Monitoring ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in